Fosun New Medicine’s Privatization and Merger with Shanghai Henlius

Kirkland & Ellis is advising China International Capital Corporation Hong Kong Securities Limited on the transaction.Shanghai Fosun New Medicine Research Company Limited, a wholly-owned subsidiary of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here